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Abstract
Activation of GABAA receptors (GABAARs) produces two forms of inhibition: ‘phasic’ inhibition
generated by the rapid, transient activation of synaptic GABAARs by presynaptic GABA release,
and tonic inhibition generated by the persistent activation of peri- or extrasynaptic GABAARs
which can detect extracellular GABA. Such tonic GABAAR-mediated currents are particularly
evident in dentate granule cells in which they play a major role in regulating cell excitability. Here
we show that in rat dentate granule cells in ex-vivo hippocampal slices, tonic currents are
predominantly generated by GABA-independent GABAA receptor openings. This tonic GABAAR
conductance is resistant to the competitive GABAAR antagonist SR95531, which at high
concentrations acts as a partial agonist, but can be blocked by an open channel blocker picrotoxin.
When slices are perfused with 200 nM GABA, a concentration that is comparable to cerebrospinal
fluid concentrations but is twice that measured by us in the hippocampus in vivo using zero-net-
flux microdialysis, negligible GABA is detected by dentate granule cells. Spontaneously opening
GABAARs, therefore, maintain dentate granule cell tonic currents in the face of low extracellular
GABA concentrations.
Introduction
In addition to fast synaptic GABAA receptor (GABAAR)-mediated signaling, there is a
slower form of signaling resulting from the tonic activation of GABAARs (Semyanov et al.,
2004; Farrant and Nusser, 2005; Glykys and Mody, 2007a). Tonically active GABAARs can
have profound effects on neuronal excitability, synaptic plasticity, network oscillations and
neurogenesis (Ge et al., 2006; Pavlov et al., 2009; Holter et al., 2010; Mann and Mody,
2010; Martin et al., 2010; Duveau et al., 2011) and have been implicated in neuronal
development, information processing, cognition and memory (Semyanov et al., 2004;
Farrant and Nusser, 2005; Brickley and Mody, 2012). The conventional view is that tonic
currents are mediated by high affinity extrasynaptic GABAARs that can detect low
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concentrations of ambient GABA, and therefore the magnitude of tonic currents is regulated
by the expression of these receptors and the availability of extracellular GABA (Semyanov
et al., 2004; Farrant and Nusser, 2005; Glykys and Mody, 2007a).
The sources and concentration of extracellular GABA ([GABA]e) are, however, still
debated. Vesicular release, “leak” through bestrophin channels and reversal of GABA
transporters have all been suggested to contribute to the extracellular GABA pool (Attwell et
al., 1993; Gaspary et al., 1998; Lee et al., 2010). In vivo estimates indicate that [GABA]e is
in the micromolar or submicromolar range (Lerma et al., 1986; Kuntz et al., 2004; Nyitrai et
al., 2006). In vitro studies have suggested even lower concentrations of GABA, in the nM
range; indeed, active uptake maintains GABA at sufficiently low concentrations to prevent
tonic GABAB receptor activation (Isaacson et al., 1993). Thus, tonic currents in
hippocampal neurons have often been measured in conditions that artificially raise [GABA]e
by inhibiting GABA uptake or metabolism, or by adding exogenous GABA to the perfusate
(Overstreet and Westbrook, 2001; Nusser and Mody, 2002; Stell and Mody, 2002; Holter et
al., 2010). When GABA is not increased by these means various magnitudes of tonic
currents have been obtained using different GABAAR antagonists (Bai et al., 2001;
Mtchedlishvili and Kapur, 2006; Zhan and Nadler, 2009; Mtchedlishvili et al., 2010). Here
we report a novel form of tonic inhibition mediated by GABA-independent openings of
GABAARs, which can explain these discrepancies.
We focus on dentate gyrus granule cells (DGCs), the excitability of which critically depends
upon the presence of tonic GABAAR-mediated conductances (Overstreet and Westbrook,
2001; Nusser and Mody, 2002; Stell and Mody, 2002; Coulter and Carlson, 2007; Holter et
al., 2010). We demonstrate that under baseline conditions, or when the perfusate contains
the same concentration of GABA that is found in cerebrospinal fluid, the major contributors
to the tonic current in DGCs are spontaneously opening GABAARs. This tonic GABAAR
conductance is resistant to the competitive GABAAR antagonist SR95531, but can be
blocked by an open channel blocker picrotoxin. On increasing [GABA]e a SR95531-
sensitive component of tonic current emerges. Together these results indicate that the
GABA-independent component of tonic current mediated by spontaneously opening
GABAARs maintains tonic inhibition in the presence of low extracellular GABA
concentrations measured in vivo.
Materials and Methods
Hippocampal slice preparation
Transverse hippocampal slices (350 μm thick) were used for in vitro electrophysiological
recordings. Slices were prepared from 3- to 4-weeks-old male Sprague Dawley rats and δ−/−
knockouts or δ+/+ littermate control mice on a C57B6 background (Herd et al., 2008;
Mihalek et al., 1999). Animals were killed by an overdose of isoflurane according to the
United Kingdom Animals (Scientific Procedures) Act of 1986. After decapitation, brains
were rapidly removed and dissected, and hippocampi were sliced with a Leica VT1200S
vibratome in ice-cold sucrose-based solution containing the following (mM): 70 sucrose, 80
NaCl, 2.5 KCl, 7 MgCl2, 0.5 CaCl2, 25 NaHCO3, 1.25 NaH2PO4, 22 glucose, equilibrated
with 95% O2 plus 5% CO2, pH 7.4, 315-330 mOsm. Slices were maintained in continuously
oxygenated sucrose-free storage solution at 33°C for 15 min, equilibrated to a room
temperature for 15 min and then placed to recover in continuously oxygenated humid
interface holding chamber at room temperature for at least 1 hour prior to recording. In
experiments with concanamycin, slices were prepared in exactly the same way but before
placing them in a holding chamber for the recovery they were incubated for 2 hours in a
submerged chamber with continuously oxygenated storage solution and 0.5μM
concanamycin. After that slices were placed in an interface holding chamber and allowed to
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rest for about half an hour prior to recording. After recovering slices were transferred into
recording chamber. The perfusion and storage medium contained (mM): 119 NaCl, 2.5 KCl,
1.3 MgSO4, 2.5 CaCl2, 26.2 NaHCO3, 1 NaH2PO4, 22 glucose and was gassed with 95% O2
and 5% CO2, pH 7.4; 290–298 mOsm.
In vitro electrophysiology
1. Whole-cell recordings: Visualized patch-clamp recordings from the mature dentate
granule cells (Rin = 310 ± 50 MΩ; Cm = 48 ± 6 pF) were performed using infrared DIC
imaging system. Tonic GABAAR-mediated currents were measured in voltage-clamp mode
(Vhold = −70 mV) in the presence of ionotropic glutamate receptor blockers DL-APV (50
μM) and NBQX (20 μM), metabotropic glutamate receptors blocker MCPG (250 μM), and
GABAB receptor blocker CGP55845 (1 μM). The intracellular pipette solution contained
(mM): 120.5 CsCl, 10 KOH-HEPES, 2 EGTA, 8 NaCl, 5 QX-314 Br- salt, 2 Mg-ATP, 0.3
Na-GTP, 10 Na-phosphocreatine, pH and osmolarity adjusted to 7.2, 295 mOsm. The tonic
GABAAR-mediated current was measured as an outward shift in holding current following
application of picrotoxin (100 μM). Changes in root mean square (RMS) noise have also
been proposed to reflect changes in tonic GABAAR-mediated conductances and have been
used because they are unaffected by current drift. Although RMS noise decreased in
experiments in which tonic currents were blocked, this measurement is confounded by the
presence of synaptic currents. Moreover, RMS noise is nonlinearly related to current, and
can paradoxically decrease when tonic currents increase (Traynelis and Jaramillo, 1998;
Glykys and Mody, 2007a). We, therefore, only used RMS noise as a measure in experiments
in which we were trying to block the tonic current. Three other GABAAR antagonists,
bicuculline methiodide (BMI) (10 μM), gabazine (SR95531) (0.5, 25 and 125 μM), and
pentylenetetrazol (PTZ) (1.5 mM) were used in experiments. Gabazine (25 μM) and
bicuculline (10 μM) were used at concentrations that would be predicted to give >90%
occupancy of GABAARs in dentate granule cells (Jones et al., 2001). Gabazine’s affinity for
GABAARs in dentate granule cells is an order of magnitude greater than that of bicuculline
(Jones et al., 2001), so that equimolar concentrations of gabazine displace bicuculline from
its binding site. Glycine receptors were blocked with 1 μM strychnine, GABAC receptors –
with 50 μM TPMPA. Recordings were performed at 32-34°C. The whole-cell pipette
resistance was 4-5.5 MΩ. Series resistance was monitored throughout experiments using a
−5mV step command. Cells showing a >20% change in a series resistance, a resistance >
20MΩ, or unstable holding current were rejected.
Acquisition and analysis
Recordings were obtained using a MultiClamp 700B or Axopatch 200B amplifier
(Molecular Devices), filtered at 4 kHz, digitized at 10 kHz, and stored on a PC. WinEDR
(The Strathclyde Electrophysiology Software) was used for data acquisition and pClamp
(Molecular Devices) and OriginPro 8.1 (OriginLab) for off-line analysis.
For analysis of tonic currents mean values of holding current during 200 ms epochs free of
synaptic currents were measured every 30 seconds. The amplitude of the tonic current was
calculated as the difference between the holding current (ΔIhold) measured 6 minutes before
and 10 minutes after the application of an antagonist. With the speed of perfusion in our
system of 3.5 ml/min this allowed full equilibration of the solution in the recording chamber.
The values of RMS noise were calculated for 200 ms epochs free of synaptic events. The
change of RMS noise (Δrms) was calculated as the difference between the values before and
after the application of an antagonist.
2. Outside-out and nucleated patch recordings—GABAAR-mediated currents were
recorded in the presence of 0.1 μM CGP55845, 100 μM D-APV, 10 μM NBQX, 200 μM S-
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MCPG, 1 μM strychnine. The intracellular pipette solution contained (mM): 120.5 CsCl, 10
KOH-HEPES, 10 BAPTA, 8 NaCl, 5 QX-314 Br- salt, 2 Mg-ATP, 0.3 Na-GTP, pH 7.2,
osmolarity 295 mOsm. Patches were pulled from dentate granule cells and recordings were
performed in voltage-clamp mode at 33-34°C (Vhold = −70 mV) using MultiClamp 700B
amplifier. Signals were digitized at 10 kHz. The patch pipette resistance was 5-7 MΩ.
For the rapid solution exchange we used a θ-glass application pipette with ~200 μm tip
diameter attached to the micromanipulator. The position of the pipette was controlled by
piezoelectric element (the speed of switch was 50-100 μs). One pipette channel was filled
with the bath aCSF solution or bath solution plus 10 μM GABA; another channel had 10
μM GABA, 25 or 125 μM SR95531, 10 μM bicuculline, or 20 μM picrotoxin. Pressure was
regulated by a PDES-02DX pneumatic micro ejector (npi electronic GmbH) using
compressed nitrogen separately in each of two channels. Solutions with SR95531,
bicuculline and picrotoxin were exchanged in a pipette channel (7-12 s) during the exposure
of nucleated patch to the bath solution channel (Bennett and Kearns, 2000; Sylantyev et al.,
2008).
Analysis of the single-channel recordings
All analyses were performed on stretches of data that were longer than 3 minutes. The
opening frequency of GABAAR-mediated channels was calculated as N/Δt, where N is the
number of openings and Δt is the time of recording. N was counted using a detection
threshold of 1.5 pA more negative than mean baseline and a minimum opening time of 0.2
ms. To calculate single-channel conductance and average open time, we first built all-points
amplitude histograms and fitted them with a two-Gaussian function:
where m1 and m2 are the mode values of Gaussians, σ1 and σ2 are the standard deviations of
corresponding modes, n is the value of electrical current, p1 and p2 are the fitting constants.
The channel conductance was calculated as G = (m2 - m1)/Vm.
Newton-Raphson iteration method was used to obtain the value of nmin, which is the value
of n at the minimum point of the function F in the interval m1 < n < m2. This was taken as
the point of channel closure. Since the signal was digitized at 10 kHz (i.e. at intervals of 0.1
ms), the average open time (in ms) was calculated as follows (the factor of 10 in the
denominator is to account for the 0.1ms interval):
where nmax = 2m2-nmin
All calculations were performed using the Wolfram Mathematica 6.2 software; the general
algorithm of histograms construction and interpretation was adapted from the paper of
Bennett and Kearns (Bennett and Kearns, 2000). We compared results obtained using this
method against those obtained by averaging all the threshold-detected openings for the data
shown in Fig. 3. There was no difference between these two methods (Pearson’s correlation
coefficient of 0.992 for open time and 0.979 for conductance).
Wlodarczyk et al. Page 4
J Neurosci. Author manuscript; available in PMC 2013 August 27.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Drugs and reagents
GABA receptor antagonists and concanamycin were purchased from Tocris Bioscience.
Other reagents were from either Ascent Scientific or Sigma-Aldrich.
In vivo microdialysis
Animals: Male Sprague-Dawley rats (Harlan, Loughborough, UK) were housed three per
cage under standard housing conditions (lights on between 05:00 - 19:00, 21 - 22 °C, 50– 60
% relative humidity) with free access to food pellets and drinking water. Animals were
handled daily (approximately 5 min/rat) starting one week before surgery and continuing
until the day of the insertion of the microdialysis probe. At the time of surgery, rats weighed
about 240 g. Surgical procedures were performed under isoflurane (Merial Animal Health
Ltd., Harlow, UK) anesthesia. Carprofen (Rimadyl, 4 mg/kg, s.c.; Pfizer, Sandwich, UK)
was administered for post-operative pain relief. All procedures were conducted in
accordance with the United Kingdom’s Animals (Scientific Procedures) Act 1986 and all
efforts were taken to minimize animal numbers and suffering.
Surgical and microdialysis procedures: Nine days before the start of the experiment, rats
were surgically prepared for microdialysis of the hippocampus by stereotaxic implantation
of a guide cannula (MAB 6.14.IC, Microbiotech/se AB, Stockholm, Sweden) essentially as
described in detail before (Droste et al., 2008). After surgery, rats were housed individually
in Plexiglas cages (length × width × height = 27 × 27 × 35 cm) under similar housing
conditions as described above.
Seven days after surgery, a microdialysis probe (polyethersulfone membrane, length 4 mm,
15-kDa cut-off, and outer diameter 0.6 mm, MAB 6.14.4, Microbiotech/se AB) was inserted
via the guide cannula into the CA3 – dentate gyrus region of the hippocampus (Linthorst et
al., 1994) under short-lasting isoflurane anesthesia (see schematics in Fig. 3C). Rats were
connected to a liquid swivel and a counterbalance arm (Microbiotech/se AB) allowing free
movement in all directions. Fluorethylenepolymer tubing with a dead volume of 1.2 μl per
100 mm length (Microbiotech) was used for all connections. Dead volumes were accounted
for during the experiment. Microdialysis probes were perfused with sterile, pyrogen-free
Ringer solution (Delta Pharma, Pfüllingen, Germany) at a flow rate of 2 μl/min using a
micro-infusion pump (KDS220, KD Scientific, Holliston, MA, USA).
The zero-net-flux experiment was started at 09:00 a.m. on the second day after the insertion
of the microdialysis probe. Ten-min samples were collected throughout the complete
experiment. After 1 hour of baseline sampling, microdialysis probes were subsequently
perfused with increasing concentrations of GABA (10, 20, 40, 80, 160 and 240 nM; Sigma-
Aldrich, Gillingham, United Kingdom) dissolved in Ringer solution (reverse microdialysis).
Each GABA perfusion lasted 40 min during which four 10-min samples were collected.
Microdialysis samples were collected using an automated, refrigerated fraction collector
(CMA470, CMA Microdialysis AB, Solna, Sweden) and were stored at −80 °C for later
HPLC analysis.
Histology: At the end of the experiment, rats were killed using an overdose of pentobarbital
(Euthatal, 200 mg/kg body weight i.p., Merial) and the brains were removed and stored in
4% buffered paraformaldehyde solution. Histological examination was performed as
described previously (Linthorst et al., 1994; Droste et al., 2008). Only data from rats with
correctly placed microdialysis probes were included in the analyses.
Measurement of GABA: High pressure liquid chromatography with electrochemical
detection was used to measure GABA in the microdialysates essentially as described
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previously with small modifications (de Groote and Linthorst, 2007). Briefly, GABA was
separated on a TARGA C18 10 cm × 1 mm column (particle size 3 μm; Higgins Analytical,
Mountain View, CA, USA) using filtered and degassed mobile phase (18% methanol, 0.1 M
NaH2PO4, 0.2 mM EDTA, pH 4.72) pumped at 50 μl/min using an Alexys LC-100 pump
(Antec Leyden BV, Zoeterwoude, The Netherlands). Standards and samples were injected
onto the column using a thermostatically controlled (8 °C) Alexys AS-100 autosampler
(Antec Leyden BV). Before injection, 13 μl standard or sample was derivatized with 2 μl of
o-phthaldialdehyde (OPA)/sulfite solution (1.6 mM OPA, 0.5% methanol, 1.88 mM
Na2SO3, 11.25 mM Na2B4O7) for 4 minutes to make GABA electrochemically active. Next,
10 μl of the derivatized mixture was injected onto the column and GABA detected using a
VT-03 electrochemical flow cell (Antec Leyden BV) set at +850 mV against an Ag/AgCl
reference electrode. Both column and detector were housed in a Faraday-shielded oven
(DECADE II, Antec Leyden BV) thermostatically controlled at 38 °C. Chromatograms were
recorded and analysed using Alexys chromatography software (Antec Leyden BV). The
detection limit for GABA at a signal-to-noise ratio of 3:1 was 11-15 fmol per injection on
column.
Calculations: Perfusion of each concentration of GABA (Cin; nM) was performed for 40
min. However, to ensure that dialysis across the membrane had reached a steady-state, the
first 10-min sample was discarded and only the three subsequent samples were used for the
calculations described below.
After measurement of the concentration of GABA in the collected samples (Cout; nM), the
difference between Cout and Cin, i.e. the net loss or gain of GABA in the dialysate, was
calculated (Cout - Cin; nM) for each concentration of GABA perfused. The baseline
condition represented Cin = 0. Next, for each individual animal, Cout - Cin was plotted
against Cin and, after regression analysis (Graphpad 5.0, La Jolla, CA, USA), the
concentration of zero-net-flux was determined as the concentration of Cin at which Cout −
Cin = 0. Next, the mean zero-net-flux concentration (± SEM; n = 5) was calculated. For
graphical purposes mean ± SEM values for Cout - Cin were calculated for each concentration
of GABA perfused and were plotted against Cin (see Fig. 3D).
Statistics—Statistical comparisons were made using paired and unpaired (as indicated in
the text/figure legends) Student’s t-test, and Wilcoxon signed ranks test (in experiments in
Fig. 1C). Differences were considered significant when P < 0.05. Data are presented in the
text and figures as mean ± SEM.
Results
Tonic activation of GABAARs in DGCs does not require synaptically released GABA
Since the accumulation of GABA in the extracellular space may result from synaptic
release, we asked whether depleting vesicular GABA by incubating hippocampal slices in
the vesicular H+-ATPase inhibitor concanamycin (0.5 μM) would affect tonic currents. We
confirmed that concanamycin abolished synaptic currents (Rossi et al., 2003), however it
had no significant effect on the magnitude of the tonic current revealed by application of the
GABAAR antagonist picrotoxin. Application of picrotoxin produced 11.9 ± 1.5 pA outward
shift in the holding current (Ihold) in control experiments, and 13.3 ± 3.0 pA shift when
slices were pre-incubated in concanamycin (Fig. 1A). These results indicate that in acute
hippocampal slices, tonic currents in DGCs are not dependent on the concentration of
GABA in vesicles or on GABA release into the synapse under baseline conditions. Glycine
receptors can contribute to inhibition in the hippocampus and may also be blocked by
picrotoxin in a use dependent manner (Danglot et al., 2004; Yang et al., 2007). We tested
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their contribution by adding the glycine receptor antagonist strychnine (1μM) and observed
that it had no effect on Ihold and did not occlude the effect of picrotoxin (ΔIhold following
application of strychnine: −0.8 ± 0.8 pA, n = 5, P = 0.40 compared to control; consecutive
application of picrotoxin: 15.6 ± 3.3 pA, n = 4, P = 0.018 compared to strychnine). We
further ruled out the potential contribution of GABACRs to picrotoxin-induced shift in Ihold
by applying the GABAC antagonist TPMPA (50 μM), which also did not affect the
amplitude of the picrotoxin-sensitive tonic current (ΔIhold following application of TPMPA:
−0.14 ± 1.78 pA, P = 0.9 compared to control; picrotoxin: 11.7 ± 1.7 pA, P = 0.006
compared to TPMPA; n = 4). Thus we conclude that neither glycine receptors, nor
GABACRs contribute to tonic conductance revealed by picrotoxin.
Tonic currents in DGCs are insensitive to SR95531 under baseline conditions
These results suggest either that [GABA]e is maintained at a constant concentration despite
decreased vesicular GABA release (e.g. by non-vesicular release), and/or that there is
another mechanism involved in generating tonic currents that is independent of [GABA]e.
To distinguish between these possibilities, we took advantage of the distinct pharmacologies
of different GABAAR antagonists. Picrotoxin is an open channel blocker and acts as a non-
competitive GABAAR antagonist that has equivalent efficacy in blocking low affinity
synaptic and high affinity extrasynaptic GABAARs (Stell and Mody, 2002). In contrast,
SR95531 is a competitive GABAAR antagonist, and displaces GABA from its binding site
(Hamann et al., 1988). Whilst low concentrations of SR95531 (0.5 μM) partially inhibited
and high concentrations (125 μM) totally blocked sIPSCs, there was no significant increase
in Ihold, which became more negative at high SR95531 concentrations (ΔIhold −6.7 ± 1.6
pA, n = 5, P = 0.014 compared to 0.5 μM SR95531, Fig. 1B, Table 1), suggesting a partial
agonist effect (this effect was not observed when SR95531 was applied after picrotoxin,
ΔIhold −1.2 ± 0.9 pA, n = 3, P = 0.3). Subsequent application of picrotoxin resulted in an
outward shift of Ihold by 18.9 ± 3.4 pA (P = 0.0049, n = 5), and a decrease in baseline RMS
noise by 0.39 ± 0.05 pA (P = 0.0012, n = 5) in the same cells (Fig. 1B). This effect of
picrotoxin was occluded by prior-application of pentylenetetrazol (Table 1), another
noncompetitive GABAAR antagonist (Huang et al., 2001). ΔIhold following application of
picrotoxin in the presence of pentylenetetrazol was 0.4 ± 0.7 pA (n = 5).
As previously reported (Semyanov et al., 2003), markedly increasing GABA in the perfusate
to 5 μM revealed a SR95531-sensitive component of the tonic current (Fig. 1C). Under
these conditions, application of a low concentration of SR95531 (0.5 μM) caused a
significant outward shift of 29.4 ± 14.4 pA in the holding current (P = 0.016, n = 8) and a
significant decrease in RMS noise by 3.0 ± 0.8 pA (P = 0.008, n = 8, Fig. 1C). Even in the
presence of a high concentration of SR95531 (125 μM) under these conditions, application
of picrotoxin caused a further outward shift in holding current by 9.2 ± 2.1 pA (P = 0.031, n
= 6), and reduction of RMS noise by 0.51 ± 0.09 pA (P = 0.003, n = 6, Fig. 1C).
The lack of efficacy of SR95531 under baseline conditions suggests that only negligible
ambient GABA can be detected by dentate granule cells. Alternatively, SR95531 may not
bind to the receptors mediating tonic current. The efficacy of SR95531 in expression
systems in which α4δ subunit-containing receptors [the main contributor to tonic currents in
dentate granule cells (Glykys and Mody, 2007b)] are expressed (Brown et al., 2002) argues
against this. Nevertheless, we tested this using another competitive GABAAR antagonist,
bicuculline. Application of bicuculline (10 μM) blocked all synaptic activity, induced a
small outward shift of holding current by 5.9 ± 0.6 pA (P = 0.00019, n = 6), and decreased
baseline RMS noise by 0.72 ± 0.11 pA (P = 0.0014, n = 6; Fig. 1D). This result can be
explained by bicuculline’s inverse agonist activity (Ueno et al., 1997; Bai et al., 2001;
McCartney et al., 2007). If SR95531 does not bind to the same receptors as bicuculline then
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it should have no effect in the presence of bicuculline. Conversely if SR95531 does bind
then it should displace the bicuculline and paradoxically induce an inward current. The
effect of bicuculline was indeed reversed by application of SR95531 (25μM), which
activated an inward current of 10.7 ± 1.7 pA (P = 0.0013, n = 6), and increased baseline
noise by 0.27 ± 0.06 pA (P = 0.008, n = 6). This was completely blocked by subsequent
application of picrotoxin (Fig. 1D). These results suggest that all three GABAAR antagonists
bind to the same receptors, and that these receptors are not detecting GABA under baseline
conditions. Moreover, the lack of effect of SR95531 here indicates that other possible
endogenous agonists (such as taurine) are also not mediating the tonic current (Jia et al.,
2008).
SR95531-insensitive tonic currents in DGCs are mediated by not only δ subunit-containing
GABAARs
Tonic GABAAR mediated currents in DGCs are predominantly mediated by α4 and δ
subunit-containing receptors (Stell and Mody, 2002; Stell et al., 2003; Caraiscos et al.,
2004). We therefore tested whether δ-GABAARs contribute to the SR95531-resistant tonic
current. We took advantage of knockout mice lacking δ subunits of GABAARs. In these
mice, in contrast to rats, there was a very small SR95531 sensitive tonic current. However,
the majority of the tonic current was SR95531-insenstive (Fig. 2). In δ−/− mice in the
presence of 25 μM SR95531, the effect of picrotoxin on holding current was ~60% less than
that in wild type mice (littermate controls), implying that δ-GABAARs contribute to
SR95531-resistant tonic currents (Fig. 2). However, there was a significant SR95531-
insensitive tonic current in δ−/− mice, suggesting that other GABAAR subtypes can also
contribute to the SR95531-insensitive tonic current in DGCs (Glykys et al., 2008).
Low [GABA]e is maintained both in vitro and in vivo
The fact that DGCs display SR95531-insensitive tonic currents suggests that [GABA]e in ex
vivo tissue is maintained at concentrations that are not detectable by high affinity
GABAARs.
We used GABAAR openings in outside-out “sniffer” patches from dentate granule cells
(Fig. 3A,B) to give a semi-quantitative estimate of [GABA]e in slices. We first confirmed
that channel openings could be recorded in outside-out patches in the presence of 10 μM
GABA (channel openings disappeared in the absence of GABA) (Fig. 3A). These channels
were blocked by picrotoxin and had an opening frequency of 20.1 ± 5.6 Hz, conductance of
39.4 ± 7.2 pS, and average open time of 32.1 ± 7.1 ms (n = 11). We were able to detect
GABAAR openings when the patch was 5 μm above the slice (0.55 ± 0.05 Hz, n = 5),
indicating that there is sufficient extracellular GABA to bind to GABAARs (Fig. 3B). These
openings did not occur when the patch was moved 300 μm above the slice and recurred on
lowering the patch again to the slice (Fig. 3B). Consequent application of 200 nM GABA to
the perfusate, comparable to that found in cerebrospinal fluid (Glaeser and Hare, 1975),
almost doubled the frequency of GABAAR openings recorded above the slice surface. The
effect of 200 nM GABA application was even more evident when patches were raised 300
μm above the slice. This indicates that [GABA]e < 200nM in the slice (Fig. 3B), and is
consistent with the predicted GABA transporter equilibrium [GABA]e of approximately 100
nM (Wu et al., 2007). We further confirmed that similarly low [GABA]e is maintained in
vivo by using the zero-net-flux microdialysis method. Microdialysis probes were inserted
into the CA3-dentate gyrus region via guide cannula, and in vivo [GABA]e was calculated
to be 92 ± 10 nM (n = 5; Fig. 3C, D).
Since an increase in GABAAR openings occurs as the patch approaches the surface, yet
there is no evidence of significant GABA-medicated tonic currents, it is likely that the
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activity of GABA transporters prevents extrasynaptic GABAA receptors from being exposed
to even such low concentrations under baseline conditions. When GABA in the perfusate
was increased to 200 nM, comparable to that found in cerebrospinal fluid (Glaeser and Hare,
1975), Ihold did not change significantly and SR95531 (25 μM) had no significant effect on
Ihold (ΔIhold following consequent application of GABA: −1.21 ± 2.03 pA, P = 0.6;
SR95531: 1.7 ± 1.4 pA, P = 0.29; n = 5), indicating that there is no increase in the GABA
detected by extrasynaptic GABAARs.
Spontaneously opening GABAARs in DGCs
The evidence thus far implies that tonic inhibition in DGCs in situ is predominantly GABA-
independent. Can tonic currents be mediated by spontaneously opening GABAARs? Such
receptors have been reported in excised patch and cell-attached recordings from
hippocampal neurons (Birnir et al., 2000a), but not in the DGCs (Birnir et al., 1994). Failure
to detect spontaneously opening GABAARs may be due to the small area sampled using
outside-out patches, and/or the dependence of such openings upon the internal neuronal
environment. Indeed, we noted that in very few excised patches (less than 10%) could we
detect infrequent channel openings (less than one every 20 seconds). We therefore
performed recordings from nucleated patches (i.e., whole-cell excisions containing intact
nuclei). In this preparation spontaneous GABAAR openings were recorded in the majority of
patches (Fig. 4). These openings had a conductance (37.4 ± 6.1 pS) similar to that observed
in excised outside-out patches with applied GABA (39 ± 7.2 pS; Fig. 3A), and comparable
to that determined in other studies (Bright et al., 2011). As expected spontaneous openings
were not affected by SR95531 (25 μM), but were fully blocked by picrotoxin (Fig. 4A-D).
Since a high concentration of SR 95521 (125 μM) had acted as a partial agonist (see Fig. 1),
we tested the effect of SR 95521 (125 μM) on spontaneous openings in nucleated patches
and, as predicted, found that it increased the frequency of openings (Fig. 4E). Addition of 10
μM GABA to the nucleated patches revealed SR95531-sensitive channels with the same
conductance (Fig. 5).
Discussion
Our results indicate that GABA-independent openings of GABAARs are the major
contributor to tonic currents in dentate granule cells ex vivo, even when GABA
concentrations in the perfusate are increased to levels comparable to those measured in vivo.
We took advantage and confirmed the different pharmacologies of GABAAR antagonists
(Table 1), and have shown that in situ DGC tonic currents are resistant to SR95531,
indicating that they are not being generated by GABA binding to the receptors. This is
consistent with similar observations in cultured neurons, other brain areas and cell types
(Birnir et al., 2000b; McCartney et al., 2007). Importantly, SR95531 has a paradoxical effect
of inhibiting the action of the inverse agonist bicuculline. This result suggests that SR95531
is displacing bicuculline from the receptors and consequently that the lack of effect of
SR95531 is not due to a failure to bind to the receptors that are mediating the tonic current.
At high concentrations (125 μM), we also found that SR95531 can act as a partial agonist. A
partial agonist effect of SR95531 (100 μM) and bicuculline (1 mM) has been described
previously at GABAARs in which there is a point mutation in the γ subunit (Ueno et al.,
1997). We did not test bicuclline at this concentration and so cannot exclude a partial
agonist effect of very high concentrations of bicuculline at extrasynaptic receptors.
This lack of GABA binding explains why inhibiting vesicular GABA release in our studies
has no effect on the tonic current. The low concentration of GABA despite vesicular release
is almost certainly due to efficient GABA uptake, as when GABA transporters are blocked,
tonic currents become dependent upon vesicular GABA release (Glykys and Mody, 2007b).
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The effect of decreasing vesicular release has variable results depending upon the nature of
the tissue studied, suggesting that GABA concentrations and the consequent detection of
extracellular GABA by GABAARs varies between brain regions. For example, in
thalamocortical neurons, 50 μM SR95531 has been demonstrated to reveal robust tonic
GABAAR-mediated currents (Cope et al., 2005). There may even be local inhomogeneities
of GABA concentrations due to regional differences in the distribution of GABA
transporters (Semyanov et al., 2003). Indirect evidence of this in the hippocampus is
supplied by the observation that tonic currents are reduced in CA1 interneurons, but not in
pyramidal cells of GAD65 deficient mice (Song et al., 2011). However, whether the
heterogeneity of extracellular GABA concentrations observed in vitro occurs in vivo is
unclear. Spontaneous openings of GABAARs have been previously described in some
preparations (e.g. in isolated hippocampal pyramidal cells and in outside-out patches from
pyramidal neurons, but not DGCs). However, the role for these spontaneous openings, and
whether they can contribute to GABAAR-mediated signaling in situ has remained unclear
(Macdonald et al., 1989; Birnir et al., 2000b). Here, we recorded from nucleated patches to
show directly that spontaneously opening receptors are present in dentate granule cells. As
predicted from other studies (McCartney et al., 2007), they are not affected by the
competitive GABAAR antagonist SR95531 and are completely blocked by the open channel
blocker picrotoxin. Lack of evidence of such openings in outside-out patches from dentate
granule cells in previous studies may be related both to the small area of membrane and also
to the effects of the internal cellular milieu on GABAAR channel gating.
A vexed question is how GABA in a slice relates to the in vivo situation. Direct
measurements of GABA in cerebrospinal fluid have revealed concentrations of the order of
200 nM (Glaeser and Hare, 1975). Using the zero-net-flux microdialysis method, we have
estimated the concentration in the extracellular fluid to be even lower. This is somewhat at
odds with an earlier study which estimated the GABA concentration in the extracellular
fluid of the hippocampus to be 800 nM (Lerma et al., 1986). This measurement however
was confounded by the complex method used to retrieve absolute concentrations from
dialysate concentrations and reliance on estimates of diffusion across the dialysis membrane.
It should also be noted that these previous estimates were done in rats under urethane
anesthesia, and sampling was performed one hour after probe implantation, when the blood-
brain-barrier could still be disrupted. The microdialysis method averages over a large area
and so we cannot exclude the possibility that the regional GABA concentrations may differ
and, in particular, that the concentration detected by neurons may be greater than this
depending upon the balance of local release and uptake; however, this was not observed by
us (and others) using the “sniffer patch” technique. Indeed, 100 nM is close to the EC20 for
extrasynaptic δ-subunit containing GABAARs (Bright et al., 2011), and so the absence of a
detectable GABA-mediated current under baseline conditions or when GABA in the
perfusate is increased to 200 nM indicates that the GABA detected by neurons is less than
that present in the extracellular space, perhaps due to efficient local GABA uptake. These
results strongly argue against the widespread addition of high GABA concentrations
(usually 5 μM) to the perfusate during ex vivo experiments. Indeed, these concentrations of
GABA are fifty fold greater than those we detect in vivo.
Our findings have several important implications. First, our results indicate that studies that
use SR95531 to measure tonic currents may significantly underestimate them. The results
may also explain discrepancies in the measurement of tonic currents in DGCs, which in one
study (and in contrast to others) was proposed not to be present in control tissue because of
the lack of effect of SR95531 (Zhan and Nadler, 2009). Furthermore the widespread use of
SR95531 and on occasions high concentrations of SR95531, which could have a partial
agonist effect, may significantly underestimate the magnitude of tonic currents present. Even
when GABA is gating the receptor, displacement by SR99531 would not prevent
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spontaneous openings, and may therefore not accurately measure the tonic current.
Moreover, our results indicate that there is always a tonic current present in dentate granule
cells even when extracellular GABA concentrations are low (as they are most of the time).
The importance of maintaining such inhibitory tone in neurons is further underscored by the
observation that knocking out receptors generating tonic current in cerebellar granule cells
leads to an upregulation of a two pore potassium channel in order to maintain the
conductance (Brickley et al., 2001).
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Figure 1.
Pharmacology of the GABAAR-mediated tonic currents in DGCs. A, Concanamycin (0.5
μM) blocks exocytosis but does not affect Itonic. No significant difference between the
change in Ihold or RMS noise in control (left trace, n = 9) and concanamycin treated slices
(right trace, n = 6) upon application of picrotoxin (PTX, 100 μM). B, Itonic in DGCs is
insensitive to SR95531 and abolished by picrotoxin. SR95531 (0.5μM) partially inhibited,
whilst high concentrations (125 μM) completely abolished sIPSCs. Picrotoxin induced an
outward shift in Ihold (P = 0.0049; n = 5), and decreased RMS noise (P = 0.0012; n = 5). C,
In the presence of GABA (5 μM), application of SR95531 (0.5 μM) reduced sIPSCs,
induced an outward shift in Ihold (P = 0.016) and decreased RMS noise (P = 0.008; n = 8).
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SR95531 (25 μM) abolished sIPSCs, induced a further non-significant shift in Ihold (P =
0.44) and RMS noise (P = 0.06; n = 5). SR95531 (125 μM) affected neither Ihold, nor RMS
noise. Consequent application of picrotoxin produced outward shift in Ihold and reduced
RMS noise (P = 0.031 and P = 0.003 respectively; n = 6). D, Bicuculline (BMI) (10 μM)
blocked all synaptic activity, induced outward shift in Ihold and reduced RMS noise (P =
0.00019 and P = 0.0014 respectively; n = 6). SR95531 (25μM) resulted in inward current
and an increase in RMS noise (P = 0.0013 and P = 0.008 respectively; n = 6), which were
reversed by picrotoxin (100 μM) (P = 0.0019 and P = 0.0048 respectively; n = 5).
Statistical comparisons were made using paired Student’s t-test in A, B and D and Wilcoxon
signed ranks test in C. * P < 0.05; ** P < 0.01; *** P < 0.001. ΔIhold and ΔRMS noise
values represent changes from the previous drug application.
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Figure 2.
δ subunit-containing GABAA receptors are involved in generating picrotoxin-sensitive tonic
currents in DGCs. The effects of SR95531 (25 μM) and picrotoxin (PTX, 100 μM) on
holding currents recorded in wild-type (top trace) and knockout mice lacking δ subunit-
containing GABAARs (bottom trace). Picrotoxin-sensitive tonic currents are reduced in the
knockout mice compared to the wild-type littermate controls (n = 9 and n = 10 for the δ+/+
and δ−/− mice respectively, ** P < 0.01, Student’s unpaired t-test). Histogram shows mean
values ± SEM.
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Figure 3.
Low extracellular GABA concentration in vitro and in vivo. A, “Sniffer” patches - outside-
out patches from DGCs display GABAAR channel openings in the presence of GABA.
Representative traces are shown on the left panel. Top: Application of 10 μM GABA to the
outside-out patches induces single-channel openings. Middle: A blow-up of the section of
the top trace marked by the vertical dashed lines. Bottom: a trace illustrating no channel
activity in the absence of GABA in perfusion solution. Right panel: normalized all-points
amplitude histogram from the experiment with 10 μM GABA application. m1 and m2 -
mean current amplitude values. Horizontal lines indicate mean amplitude values of an open
(O) and closed (C) state. B, The frequency of channel opening in the “sniffer” patch close to
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slice surface (5 μm above DGC layer) and in the bath (300 μm above the slice surface) with
and without 200 nM GABA in the perfusion solution (sample traces from the same patch at
different conditions are shown on the left). Bar charts show (from top to bottom on the right)
normalized values of channel opening frequency, open time and conductance ± SEM (n = 5;
* P < 0.05; ** P < 0.01; *** P < 0.001, paired Student’s t-test). C, Estimation of [GABA]e
in the rat hippocampus was performed using zero-net-flux microdialysis. Locations of the
microdialysis probes in the hippocampus from 5 rats are shown by the black circles on the
schematic of a horizontal section of rat brain (Paxinos and Watson, 2007). D, After
collection of six baseline samples, the microdialysis probe was perfused with increasing
concentrations of GABA (Cin; 10-240 nM) by reverse dialysis. The baseline condition
represents Cin = 0. The concentration of GABA in the collected samples (Cout; nM) was
determined by HPLC with electrochemical detection. The net loss or gain of GABA in the
dialysate (Cout - Cin; nM) was calculated and plotted against the concentration of GABA in
the perfusion fluid (Cin). The intercept with the dashed line (y = 0) is the concentration of
GABA at which Cout = Cin represents an estimate of the [GABA]e (n=5).
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Figure 4.
Spontaneous GABAAR channel openings in nucleated patches. A, Left: representative traces
illustrating single-channel openings, top to bottom: control, SR95531 (25 μM), picrotoxin
(20 μM). Lower traces are expanded segments indicated by vertical dashed lines on the
upper traces. Right: normalized all-points amplitude histograms. m1 and m2, - mean current
amplitude values. Channel opening frequency (B), conductance (C) and average open time
(D) normalized to control values (n = 5 nucleated patches). E, Application of 125 μM
SR95531 increases the frequency of spontaneous channel openings. Left: sample traces;
right: spontaneous channel opening frequency, open time and conductance normalized to
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control values (n = 5). Horizontal dashed lines indicate an open (O) and closed (C) state. * P
< 0.05; *** P < 0.001, paired t-test, W/O – washout.
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Figure 5.
Application of GABA to nucleated patches from dentate granule cells induces SR95531-
sensitive channel openings. A, Left panel: Representative traces illustrating single-channel
openings at consecutive stages of the experiment carried out in the presence of 10 μM of
GABA. From top to bottom: control, SR95531 (25 μM), washout of SR95531. Horizontal
dashed lines indicate mean amplitude values of an open (O) and closed (C) state. Right
panel: normalized all-points amplitude histograms. m1, m2, m3 - mean current amplitude
values. Normalized average opening frequency (B), conductance (C) and open time (D) of
channel openings induced by GABA application (n = 5 nucleated patches). ** P < 0.01, ***
P < 0.001, paired Student’s t-test; W/O – washout.
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Table 1
The effect of different GABA antagonists in control conditions with no GABA added.
Antagonist GABA tonic current (ΔIhold, pA)
PTX (100 μM) 11.9 ± 1.5, n = 9, P = 0.00004 compared to control
Pentylenetetrazol (1.5 mM) 10.6 ± 3.6, n = 5, P = 0.04 compared to control
Bicuculline (10 μM) 5.9 ± 0.6, n = 6, P = 0.0002 compared to control
SR95531 (125 μM) −6.7 ± 1.6, n = 5, P = 0.01 compared to control
PTX (100 μM) in SR95531 (125 μM) 18.9 ± 3.4, n = 5, P = 0.005 compared to SR95531
(125 μM)
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